Nirsevimab: Expansion of Respiratory Syncytial Virus Prevention Options in Neonates, Infants, and At-Risk Young Children.

Autor: Fly, J. Hunter, Eiland, Lea S., Stultz, Jeremy S.
Zdroj: Annals of Pharmacotherapy; Jan2025, Vol. 59 Issue 1, p81-91, 11p
Databáze: Supplemental Index